Live Breaking News & Updates on State Drug Administration

Stay updated with breaking news from State drug administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA

Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United States , National Center , Akeso Inc , Drug Evaluation , State Drug Administration , New Drug Application , Summit Therapeutics , Breakthrough Therapy Designation , Priority Review ,

Akeso Announced NDA Acceptance of IL-12/lL-23 Monoclonal Antibody Ebdarokimab for Moderate-to-severe Plaque Psoriasis by China NMPA

HONG KONG, Aug. 24, 2023 /PRNewswire/ Akeso Inc. , a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines. ....

Hong Kong , Prnewswire Akeso Inc , Akeso Inc , National Center , New Drug Application , Drug Evaluation , State Drug Administration , Summit Therapeutics , Main Board , Stock Exchange ,